XML 17 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities    
Net income $ 2,317,107 $ 2,020,455
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Depreciation and amortization 694,497 569,897
Gain on disposal of fixed assets (32,017) (20,296)
Allowance for doubtful accounts (118,881) (33,017)
Stock compensation 289,596 0
Deferred taxes (63,000) 265,000
(Increase) decrease in    
Accounts receivable - billed (3,460,732) (3,149,856)
Accounts receivable - unbilled 76,068 (97,435)
Inventories (418,502) (13,296)
Prepaid expenses and other assets (149,086) (110,709)
Refundable income taxes 96,395 355,597
Accounts payable - trade 462,023 266,769
Accrued expenses and other liabilities 178,589 261,816
Deferred revenue 621,415 175,839
Accrued compensation 131,606 199,149
Customer deposits 1,050,546 195,799
Net cash provided by operating activities 1,675,624 885,712
Cash flows from investing activities:    
Purchases of investment securities available-for-sale (28,594) (31,990)
Purchases of property and equipment (2,568,788) (3,289,669)
Proceeds from sale of fixed assets 37,369 20,296
Net cash used in investing activities (2,560,013) (3,301,363)
Cash flows from financing activities:    
Line of credit borrowings 0 1,450,000
Line of credit payments 0 (1,450,000)
Proceeds from long-term borrowings 183,784 1,887,322
Repayments of long-term borrowings (434,876) (310,357)
Dividends paid on common stock (49,414) 0
Proceeds from options exercised 116,778 48,400
Net cash (used in) provided by financing activities (183,728) 1,625,365
Net decrease in cash and cash equivalents (1,068,117) (790,286)
Cash and cash equivalents    
Beginning of period 3,522,620 1,735,621
End of period $ 2,454,503 $ 945,335